Substituted carbostyril derivatives as 5-HT1A receptor subtype agonists

Details for Australian Patent Application No. 2002226752 (hide)

International Classifications

Event Publications

20 February 2003 Application Open to Public Inspection

Published as AU-B-2002226752

17 March 2005 Application Accepted

Published as AU-B-2002226752

14 July 2005 Standard Patent Sealed

25 June 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Mar 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

1 October 2009 Licence Registered

Otsuka Pharmaceutical Co., Ltd. ( Bristol-Myers Squibb Company )

8 October 2009 Opposition Lodged under Section 104(4)

Apotex Pty Ltd has lodged an opposition against Otsuka Pharmaceutical Co., Ltd.

28 January 2010 Opposition Withdrawn

The opposition by Apotex Pty Ltd against Otsuka Pharmaceutical Co., Ltd has been withdrawn.

18 February 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Mar 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.